Is bone marrow biopsy needed in staging small cell carcinoma?

E. Torun, B. Caglayan, A. Fidan, B. Salepci (Istanbul, Turkey)

Source: Annual Congress 2006 - Screening, diagnosis, staging, prognosis, biological features
Session: Screening, diagnosis, staging, prognosis, biological features
Session type: E-Posters in free access
Number: 570
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Torun, B. Caglayan, A. Fidan, B. Salepci (Istanbul, Turkey). Is bone marrow biopsy needed in staging small cell carcinoma?. Eur Respir J 2006; 28: Suppl. 50, 570

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Nonsmall cell lung carcinoma: diagnostic difficulties in small biopsies and cytological specimens
Source: Eur Respir Rev, 26 (144) 170007; 10.1183/16000617.0007-2017
Year: 2017



Usefulness of bone metabolic markers in the bone metastasis from lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 269s
Year: 2002

Bone marrow involvement in esophageal cancer patients whom undergone surgical resection
Source: Annual Congress 2010 - Oncological problems, surgical risk and complications
Year: 2010

Bone marrow metastases in non-small cell lung cancer patients – a role of flow cytometry
Source: Eur Respir J 2006; 28: Suppl. 50, 782s
Year: 2006

Ultrasound guided true cut biopsy of peripheral lymph nodes as a staging procedure in patients with non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – EBUS and transthoracic ultrasound
Year: 2016


Primary giant cell tumour of bone in the lung
Source: Eur Respir J 2002; 20: Suppl. 38, 467s
Year: 2002

Bone metabolic markers in detecting bone metastasis of lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010

Prognostic significance of cytokeratin positive cells in bone marrow of non-small cell lung cancer patients
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008


Large adrenal metastasis in non small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 94s
Year: 2006

Small cell lung cancer – possibility and difficulties in cytological diagnosis
Source: Eur Respir J 2006; 28: Suppl. 50, 81s
Year: 2006

Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease?
Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018
Year: 2019



The role of bisphosphonates in lung cancer patients with bone metastases
Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology
Year: 2007


The role of VATS in the staging of non small cell lung cancer
Source: Annual Congress 2011 - General thoracic surgery I
Year: 2011

Detection of bone metastases in patients with lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 65s
Year: 2001

Bone metastases of bronchial cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 77s
Year: 2002

Survival of lung cancer patients with bone metastases
Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Year: 2011

Telomerase activity, micrometastasis and lynphonodal metastasis in resected non small cell lung cancer
Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology
Year: 2008


Interobserver agreement in determining non-small cell lung cancer subtype in specimens acquired by EBUS-TBNA},
Source: Eur Respir J 2012; 40: 699-705
Year: 2012



Extrathoracic 18-FDG-PET uptakes in non small cell lung cancer (NSCLC) preoperative staging
Source: Eur Respir J 2007; 30: Suppl. 51, 430s
Year: 2007

Are there potential characteristical markers in bronquial fluid for diagnosis of small cell lung cancer (SCLC)?
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009